MPG, HIV related is 27-aa peptide, derived from both the nuclear localisation sequence of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41 and is a potent delivery agent for the generalised delivery of nucleic acids and of oligonucleotides into cultured cells.
MPG, HIV related, is a synthetic peptide compound designed to facilitate intracellular delivery of biologically active molecules, notably nucleic acids and proteins, into mammalian cells. Characterized by its amphipathic sequence, MPG is derived from the fusion of HIV-1 gp41 and the nuclear localization sequence of SV40 large T antigen, endowing it with notable membrane translocation capabilities. Its unique structure enables it to form non-covalent complexes with a range of cargo molecules, thereby overcoming the inherent barriers posed by cellular membranes. As a versatile molecular tool, MPG has become highly relevant in biochemical research focused on gene transfer, molecular delivery systems, and the study of intracellular trafficking mechanisms.
Gene Delivery: MPG peptide is extensively utilized in the development of non-viral gene delivery systems. By forming stable complexes with nucleic acids such as plasmid DNA, siRNA, or oligonucleotides, it enables efficient translocation across cellular membranes without the cytotoxicity or immunogenicity often associated with viral vectors. Researchers leverage this property to investigate gene function, conduct gene knockdown experiments, and optimize transfection protocols in a variety of mammalian cell lines. Its ability to mediate delivery in both adherent and suspension cultures makes it a valuable tool for laboratories seeking alternatives to traditional transfection reagents.
Protein Transduction: Beyond nucleic acids, MPG is applied in the delivery of functional proteins and peptides into living cells. The peptide's amphipathic nature facilitates the formation of non-covalent complexes with diverse protein cargos, allowing these macromolecules to bypass endocytic pathways and directly access the cytoplasm. This application is particularly significant for studies requiring rapid and efficient intracellular delivery of enzymes, antibodies, or regulatory peptides, enabling real-time analysis of protein function, localization, and cellular response.
Intracellular Trafficking Research: MPG serves as a model system for dissecting the mechanisms of membrane translocation and endosomal escape. Its well-characterized sequence and predictable behavior make it ideal for mechanistic studies aimed at understanding the dynamics of peptide-mediated transport. Researchers employ MPG to probe the interactions between delivery peptides and cellular membranes, elucidate the factors influencing uptake efficiency, and design improved vectors for molecular delivery. Such insights contribute to the broader field of cellular trafficking and the development of next-generation delivery technologies.
High-Throughput Screening: The peptide's robust and reproducible delivery capability supports its use in high-throughput screening platforms. By enabling uniform and efficient introduction of nucleic acids or proteins into large cell populations, MPG streamlines screening assays for gene function, drug target validation, or phenotypic analysis. Its compatibility with automated workflows and diverse cell types enhances the scalability and reliability of screening campaigns, facilitating the identification of novel biological targets and functional pathways.
Peptide Engineering and Delivery System Optimization: MPG is also employed as a reference compound in the rational design and optimization of novel cell-penetrating peptides. Its sequence serves as a template for structure-activity relationship studies, guiding modifications aimed at enhancing delivery efficiency, cargo specificity, or cellular targeting. Comparative studies using MPG inform the development of custom peptide vectors tailored to specific research needs, advancing the field of peptide-mediated molecular delivery and broadening the range of applications in molecular and cellular biology.
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.